View in EDS HTML Full Text PDF Full Text

Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.

Saved in:
Bibliographic Details
Title: Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
Authors: Tuttle KR; Providence Healthcare, University of Washington, Spokane, Washington, USA., Wilson JM; Eli Lilly and Company, Indianapolis, Indiana, USA., Lin Y; Eli Lilly and Company, Indianapolis, Indiana, USA., Qian HR; Eli Lilly and Company, Indianapolis, Indiana, USA., Genovese F; Nordic Bioscience, Herlev, Denmark., Karsdal MA; Nordic Bioscience, Herlev, Denmark., Duffin KL; Eli Lilly and Company, Indianapolis, Indiana, USA., Botros FT; Eli Lilly and Company, Indianapolis, Indiana, USA.
Source: American journal of nephrology [Am J Nephrol] 2023; Vol. 54 (1-2), pp. 74-82. Date of Electronic Publication: 2023 Feb 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 8109361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9670 (Electronic) Linking ISSN: 02508095 NLM ISO Abbreviation: Am J Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36754023
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tuttle+KR%22">Tuttle KR</searchLink>; Providence Healthcare, University of Washington, Spokane, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+JM%22">Wilson JM</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Lin+Y%22">Lin Y</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Qian+HR%22">Qian HR</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Genovese+F%22">Genovese F</searchLink>; Nordic Bioscience, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Karsdal+MA%22">Karsdal MA</searchLink>; Nordic Bioscience, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Duffin+KL%22">Duffin KL</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Botros+FT%22">Botros FT</searchLink>; Eli Lilly and Company, Indianapolis, Indiana, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228109361%22">American journal of nephrology</searchLink> [Am J Nephrol] 2023; Vol. 54 (1-2), pp. 74-82. <i>Date of Electronic Publication: </i>2023 Feb 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>8109361 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1421-9670 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202508095%22">02508095 </searchLink><i>NLM ISO Abbreviation: </i>Am J Nephrol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36754023
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000529374
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 74
    Titles:
      – TitleFull: Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tuttle KR
      – PersonEntity:
          Name:
            NameFull: Wilson JM
      – PersonEntity:
          Name:
            NameFull: Lin Y
      – PersonEntity:
          Name:
            NameFull: Qian HR
      – PersonEntity:
          Name:
            NameFull: Genovese F
      – PersonEntity:
          Name:
            NameFull: Karsdal MA
      – PersonEntity:
          Name:
            NameFull: Duffin KL
      – PersonEntity:
          Name:
            NameFull: Botros FT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1421-9670
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 1-2
          Titles:
            – TitleFull: American journal of nephrology
              Type: main
ResultId 1